Wirick Angela L 4
4 · AtriCure, Inc. · Filed Mar 5, 2024
Insider Transaction Report
Form 4
AtriCure, Inc.ATRC
Wirick Angela L
Chief Financial Officer
Transactions
- Award
Common Stock
2024-03-01+31,008→ 117,609 total - Award
Common Stock
2024-03-01+16,461→ 134,070 total - Exercise/Conversion
Common Stock
2024-03-01$16.95/sh+5,000$84,750→ 139,070 total - Exercise/Conversion
Non-qualified Stock Option (right to buy)
2024-03-01$16.95/sh−5,000$84,750→ 0 totalExercise: $16.95From: 2015-07-28Exp: 2024-07-28→ Non-qualified Stock Option (right to buy) (5,000 underlying)
Footnotes (3)
- [F1]The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.
- [F2]The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met.
- [F3]These options were granted on July 28, 2014. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.